The Promoting the Quality of Medicines (PQM) program, helps low- and middle-income countries strengthen the systems that ensure the quality and increase the supply of priority medicines. Funded by USAID, the PQM program is implemented by USP.
PQM has worked in over 40 low- and middle-income countries since the program began in 2009. With activities in 24 countries, the program partners with regulators and manufacturers to ensure the quality and increase the supply of priority medicines.
Read the 2018 annual report to see how we are expanding access to quality-assured medicines.
PQM was instrumental in increasing the global supply of quality-assured anti-TB medicine while also helping to decrease its cost for public health programs and patients.
Detecting poor-quality antimalarials and removing them from the market, as well as increasing the availability of quality-assured antimalarials, is critical. On their journey to self-reliance, Nigerian regulators have enhanced technical skills and strengthened laboratory capacity so they can survey and test medicines in their own market, with the help of PQM.
Without a local supply of Quality-assured chlorhexidine, countries are vulnerable to fluctuations in foreign pricing and availability. PQM identified, supported and worked toward market authorization for two manufacturers of chlorhexidine gel in Pakistan.
Helping Liberia control falsified and substandard medicines from streaming into the country by building customs officers’ capacity to test medicines at the border.
Poor-quality condoms in the African market posed risks of HIV transmission. Now Ethiopia’s national laboratory can confidently identify them and halt their distribution.
A 24-year-old pharmaceutical regulatory law in Guinea gets updated in 2018 to help ensure the quality of medicines and reinforce the supply chain. Efforts to update the law were punctuated by the 2014-2016 Ebola epidemic.
Increasing the availability of quality-assured medicines is essential for saving thousands of mothers’ and children’s lives.
Bangladesh’s Directorate General of Drug Administration turned to the PQM program to ensure its National Control Laboratory could meet and maintain ISO/IEC 17025:2017 standards.
When is an airline a critical part of the healthcare system? When countries—such as Ethiopia—must import life-saving medicines.
Quality medicines underpin all AMR strategies and are essential to limiting the emergence and geographic spread of antimicrobial resistance. Together we can address this important global advocacy agenda issue.
Millions of people around the world lack access to quality medicines. Medicines We Can Trust is a global collaborative campaign highlighting the human impact of poor-quality medicines and advocating for the right to safe and quality medicines for everyone, everywhere.
Faced with poor-quality medicines, health leaders around the world need more data to make strategic decisions about investments. The Quality Institute is developing research addressing evidence gaps, ultimately strengthening understanding of the value of quality medicines.
Supply chain security requires a multilayer approach that includes prevention, detection, and response strategies and actions. USP, a designated Center of Excellence by the Asia-Pacific Economic Cooperation, is helping enhance implementation and sustainability of supply chain integrity to protect medicines quality.
USP works in cooperation with the U.S. Food and Drug Administration and other Federal, State, and local agencies, practitioners, academia, industry and other stakeholders.
Through international policy and regulatory analysis, advocacy, and collaboration with governments, multilateral institutions, regional cooperation initiatives and private sector engagement USP is helping advance the quality and safety of medicines across the globe.
Coordination and collaboration among country and regional stakeholders support system strengthening. USP fosters south-south collaboration by promoting resource-sharing, harmonization, joint data collection and information-sharing.